Fig. 2.
Fig. 2. Western blot analysis of murine plasma using an 2-AP–specific (A) or a plasminogen-specific (B and C) antiserum. (A) Lane 1, purified murine 2-AP; lanes 2 and 3, 2-AP+/+ and 2-AP−/− plasma. (B) Lanes 1 and 2, 2-AP+/+ and 2-AP−/− plasma after incubation with human plasmin (final concentration, 1 μmol/L) for 10 seconds at 37°C. (C) Lanes 1 and 2, 2-AP+/+ and 2-AP−/− plasma; lanes 3 and 4, 2-AP+/+ and 2-AP−/− plasma activated with tcu-PA (final concentration, 50 nmol/L) for 1 hour at 37°C; lane 5, purified murine plasminogen.

Western blot analysis of murine plasma using an 2-AP–specific (A) or a plasminogen-specific (B and C) antiserum. (A) Lane 1, purified murine 2-AP; lanes 2 and 3, 2-AP+/+ and 2-AP−/− plasma. (B) Lanes 1 and 2, 2-AP+/+ and 2-AP−/− plasma after incubation with human plasmin (final concentration, 1 μmol/L) for 10 seconds at 37°C. (C) Lanes 1 and 2, 2-AP+/+ and 2-AP−/− plasma; lanes 3 and 4, 2-AP+/+ and 2-AP−/− plasma activated with tcu-PA (final concentration, 50 nmol/L) for 1 hour at 37°C; lane 5, purified murine plasminogen.

Close Modal

or Create an Account

Close Modal
Close Modal